Cigler Tessa bought ATOS

March 9, 2024 · Form 4 insider transaction

Cigler Tessa bought 20,834 shares of Atossa Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
20,834
Price
$0.00
Total value
N/A
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 9, 2024
Filing dateMarch 14, 2024
Shares owned after20,834
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The options shall vest in four equal quarterly installments following March 9, 2024, subject to the Reporting Person's continued service through each applicable date.

View the original Form 4 on SEC EDGAR